
Jan 6 (Reuters) -
FDA PROPOSES UPDATED RECOMMENDATIONS TO HELP IMPROVE PERFORMANCE OF PULSE OXIMETERS ACROSS SKIN TONES
FDA: UPDATED DRAFT RECOMMENDATIONS AIMED AT HELPING GENERATE A MORE REPRESENTATIVE STUDY OF INTENDED POPULATION FOR PULSE OXIMETERS
FDA: CURRENT SCIENTIFIC EVIDENCE SUGGESTS THERE ARE SOME ACCURACY DIFFERENCES IN PULSE OXIMETER PERFORMANCE BETWEEN DIFFERENT SKIN PIGMENTATION
FDA: PROPOSED NEW DRAFT RECOMMENDATIONS ON HOW TO GATHER CLINICAL DATA TO IMPROVE STUDY DESIGN FOR PULSE OXIMETERS, ACROSS RANGE OF SKIN PIGMENTATION
FDA-EXPECTS SOME PULSE OXIMETERS CURRENTLY MARKETED MAY MEET UPDATED PERFORMANCE CRITERIA WITHOUT NEED FOR SIGNIFICANT HARDWARE/SOFTWARE MODIFICATIONS
((Reuters.Briefs@thomsonreuters.com;))